Ranking Vaccines A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System |
|
Author:
| Institute of Medicine, Board on Global Health, Board on Population Health and Public Health Practice, Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase II, |
Editor:
| King, Lonnie Martinez, Rose-Marie Rappuoli, Rino Fryback, Dennis Phelps, Charles Sangha, Kinpritma Madhavan, Guruprasad |
ISBN: | 978-0-309-26639-0 |
Publication Date: | Sep 2013 |
Publisher: | National Academies Press
|
Book Format: | Ebook |
List Price: | Contact Supplier contact
|
Book Description:
|
SMART Vaccines-Strategic Multi-Attribute Ranking Tool for Vaccines-is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I.
Ranking Vaccines: A Prioritization Software Tool,Phase II extends the...
More Description
SMART Vaccines-Strategic Multi-Attribute Ranking Tool for Vaccines-is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I.
Ranking Vaccines: A Prioritization Software Tool,Phase II extends the proof-of-concept presented in the Phase I report, which was based on multi-attribute utility theory. This report refines a beta version of the model developed in the Phase I report and presents its next iteration, SMART Vaccines 1.0.
Ranking Vaccines: Phase II discusses the methods underlying the development, validation, and evaluation of SMART Vaccines 1.0. It also discusses how SMART Vaccines should-and, just as importantly, should not-be used. The report also offers ideas for future enhancements for SMART Vaccines as well as for ideas for expanded uses and considerations and possibilities for the future.